Price alert —
Sign in to get a one-time email the moment ABBV crosses your price. Free accounts included.
Sign in / create a free accountAbbVie Inc. is a healthcare company listed in the US.
ABBV last traded at $254.49, up 0.0% on the day; that's in the upper part of its 52-week range ($190.75–$261.64). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
Our cash-flow model pegs fair value near $282.41 (fair range $37–$282); today's price leaves a +13% cushion below that estimate. The model's verdict is “Undervalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ Gross margin 72% (pricing power)
- ⚠ Debt exceeds cash
- ⚠ Quick ratio 0.51 (fragile)
- ⚠ Current ratio 0.67 (fragile)
- ⚠ Negative retained earnings
Price implies ~10% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
ABBV is a $438.2 billion company, priced at 121× last year's earnings, and the stock is trading near the top of its 52-week range.